
Fortress Biotech, Inc.
FBIONasdaqCIK 1429260HealthcareFiscal year ends Dec 31
Reports and events: 360 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-02-0917:03 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-001085 |
| 2023-01-1316:13 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-003820 |
| 2023-01-1316:13 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-003819 |
| 2023-01-0616:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-001875 |
| 2022-12-1908:26 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-22-018778 |
| 2022-11-1417:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-017843 |
| 2022-11-1416:16 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-017763 |
| 2022-11-0416:06 ET | 8-K | 3.01 Delisting notice | 0001104659-22-114895 |
| 2022-10-2816:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-112516 |
| 2022-08-1116:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-013330 |
| 2022-08-1116:08 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-013275 |
| 2022-07-2216:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-22-010916 |
| 2022-07-1116:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-22-010620 |
| 2022-06-2716:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-22-010325 |
| 2022-05-1216:18 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-008557 |
| 2022-05-1216:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-008553 |
| 2022-05-0217:37 ET | DEF 14A | Proxy statementPeriod 2022-06-21 | 0001558370-22-006515 |
| 2022-03-2816:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-004487 |
| 2022-03-2808:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-038430 |
| 2021-12-0708:01 ET | 8-K | 8.01 Other events | 0001104659-21-147022 |
| 2021-11-1516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-139179 |
| 2021-11-1516:06 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-015968 |
| 2021-10-2708:16 ET | 8-K | 8.01 Other events | 0001104659-21-130293 |
| 2021-10-0616:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-123641 |
| 2021-09-2907:45 ET | 8-K | 8.01 Other events | 0001104659-21-120460 |
| 2021-09-2816:10 ET | 8-K | 4.01 Change of auditor; 8.01 Other events | 0001104659-21-120228 |
| 2021-09-2417:19 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-21-119377 |
| 2021-08-2717:02 ET | 8-K | 8.01 Other events | 0001104659-21-110598 |
| 2021-08-1616:14 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-011812 |
| 2021-08-1616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-106288 |
| 2021-07-2917:01 ET | 8-K | 8.01 Other events | 0001104659-21-097648 |
| 2021-07-1519:17 ET | 8-K | 8.01 Other events | 0001104659-21-092208 |
| 2021-06-2316:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-21-084632 |
| 2021-06-1716:21 ET | 8-K | 8.01 Other events | 0001104659-21-082624 |
| 2021-05-1716:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-068111 |
| 2021-05-1716:07 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001558370-21-007395 |
| 2021-04-3016:02 ET | DEF 14A | Proxy statementPeriod 2021-06-17 | 0001104659-21-058972 |
| 2021-04-1317:13 ET | 8-K | 8.01 Other events | 0001104659-21-049816 |
| 2021-04-0917:29 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001558370-21-004130 |
| 2021-04-0107:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-045172 |
| 2021-03-3116:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-044779 |
| 2021-03-3116:03 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001558370-21-003815 |
| 2021-02-2408:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-027164 |
| 2020-12-2817:06 ET | SC 13D | Ownership report, active investor | 0001104659-20-139861 |
| 2020-11-0916:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-20-123101 |
| 2020-11-0916:07 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001558370-20-013349 |
| 2020-08-2808:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-099794 |
| 2020-08-2808:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001104659-20-099792 |
| 2020-08-1016:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-20-092784 |
| 2020-08-1016:02 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001104659-20-092702 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:27 ET. Listed shows no prices and gives no investment advice.